

Bence Jones proteins, also known as BJ proteins, are composed of light chains (either kappa or lambda) produced by plasma cells. Normally, plasma cells secrete antibodies in the form of immunoglobulins, which are composed of both heavy and light chains. However, in some health conditions, like multiple myeloma, the plasma cells begin to synthesize an excessive amount of light chain that enters the blood. Some of these free light chains are filtered via the kidneys and excreted into the urine, where they are known as Bence Jones proteins.
The Bence Jones Protein, Urine (Qualitative) test is often recommended if there are signs and symptoms indicative of multiple myeloma or lymphoproliferative disorders, such as bone pain, fatigue, recurrent infections, or weight loss for no apparent reason. It may also be advised for individuals with a family history or hereditary predisposition (genetic factor) for multiple myeloma, or if other blood tests indicate possible abnormalities in plasma cell function or lymphoproliferative conditions. Additionally, this test is valuable in monitoring treatment effectiveness, as it can help determine whether Bence Jones protein levels are decreasing or stabilizing over time.
Ensure drinking enough water in order to give a urine sample. The individual must provide midstream urine (obtained after the first and before the last thump of urine) in the sterile, sealed container given by the laboratory personnel. Women are advised not to give the sample during the menstrual period unless prescribed. Inform the doctor about all the medications or supplements being taken, as these may affect the test results, potentially requiring adjustments or temporary discontinuation before the test.
Avoid self-medicating at home based only on these results. Seek a doctor when it comes to interpreting the test results. Explain the entire medical history for the doctor to match the clinical data with laboratory investigations. The results will help them determine the medical condition and formulate a treatment plan.
The Bence Jones Protein, Urine (Qualitative) test measures the presence of Bence Jones proteins, which are free light chains (either kappa or lambda) found in the urine. These proteins are produced when plasma cells in the bone marrow become abnormal and start to secrete excess light chains. In normal circumstances, light chains bind with heavy chains to form immunoglobulins (antibodies), but in plasma cell disorders, the excess light chains are not bound and are released into the blood and subsequently filtered out through the kidneys. This test helps detect these proteins in the urine, providing key insights into the presence and severity of plasma cell disorders. Furthermore, it indicates how well the kidneys are functioning.
The Bence Jones Protein, Urine (Qualitative) test is done:
- To diagnose disorders associated with plasma cells like multiple myeloma (a type of blood cancer).
- To help evaluate kidney damage or dysfunction often caused by excess light chains in the urine.
- To monitor disease severity in conditions like multiple myeloma or amyloidosis.
- To evaluate the response of ongoing treatment for plasma cell disorders.
- In cases of symptoms such as unexplained bone pain, anemia, recurrent infections, or kidney problems.
- To diagnose and monitor other lymphoproliferative disorders that may involve abnormal protein production.
- A midstream urine sample is preferred—that is, the portion of urine collected after the initial flow and before the final stream. Collect the urine sample in a sealed and sterile container provided by our sample collection professional. Make sure that the container doesn't come in contact with your skin. Women are advised not to give the sample during the menstrual period unless prescribed.


































